Overview

Efficacy and Safety of Dapagliflozin in Children With Proteinuria

Status:
Recruiting
Trial end date:
2022-06-30
Target enrollment:
Participant gender:
Summary
The purpose of the study is to investigate the antiproteinuric effect of Dapagliflozin in children with proteinuria.
Phase:
Phase 4
Details
Lead Sponsor:
Children's Hospital of Fudan University
Treatments:
2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol
Dapagliflozin